EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The programed death‐1/programed death ligand‐1 axis and its potential as a therapeutic target for virus‐associated tumours

Jing Li, Yan Zhang, Bing Luo iD

Reviews in Medical Virology · 2024

DOI: 10.1002/rmv.2486 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2024. Verfasst von Jing Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 139 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As an important and serious condition impacting human health, the diagnosis, and treatment of tumours is clinically vital because tumour cell immune escape sustains tumour development. Programed death ligand‐1 (PD‐L1) on tumour cell surfaces binds to the programed death‐1 (PD‐1), inhibits T cell activation, and induces apoptosis, and incapacitates cells. This allows tumour cells to evade recognition and clearance by the immune system, thereby permitting tumour occurrence, and development and poor prognosis outcomes in patients with tumours. Currently, anti‐PD‐1/PD‐L1 immunotherapy has become pivotal in tumour treatment. Pathogens, especially viruses, are important factors which induce many tumours. In this article, we examine associations between Epstein‐Barr virus, human papilloma virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1‐related tumours and PD‐1/PD‐L1 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsNeoplasmsHumansHerpesvirus 4, HumanB7-H1 AntigenProgrammed Cell Death 1 ReceptorLigands

Stichwörter der Autor:innen

PD-1/PD-L1cancersoncovirus

Substanzen

B7-H1 AntigenProgrammed Cell Death 1 ReceptorLigands

Autor:innen und Institutionen

  • Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, China.
  • Department of Clinical Laboratory, Zibo Central Hospital, Zibo, China.

ORCID-Profile: Bing Luo

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

Li, J., Zhang, Y., & Luo, B. (2024). The programed death‐1/programed death ligand‐1 axis and its potential as a therapeutic target for virus‐associated tumours. Reviews in Medical Virology. https://doi.org/10.1002/rmv.2486

Vancouver

Li J, Zhang Y, Luo B. The programed death‐1/programed death ligand‐1 axis and its potential as a therapeutic target for virus‐associated tumours. Reviews in Medical Virology. 2024. doi:10.1002/rmv.2486

BibTeX
@article{Li2024,
  author = {Li, Jing and Zhang, Yan and Luo, Bing},
  title = {The programed death‐1/programed death ligand‐1 axis and its potential as a therapeutic target for virus‐associated tumours},
  journal = {Reviews in Medical Virology},
  year = {2024},
  doi = {10.1002/rmv.2486}
}
Kostenlos starten →